Mackenzie A. Scully

511 total citations
11 papers, 403 citations indexed

About

Mackenzie A. Scully is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Mackenzie A. Scully has authored 11 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Biomaterials and 5 papers in Biomedical Engineering. Recurrent topics in Mackenzie A. Scully's work include RNA Interference and Gene Delivery (7 papers), Nanoparticle-Based Drug Delivery (6 papers) and Nanoplatforms for cancer theranostics (5 papers). Mackenzie A. Scully is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Nanoparticle-Based Drug Delivery (6 papers) and Nanoplatforms for cancer theranostics (5 papers). Mackenzie A. Scully collaborates with scholars based in United States and France. Mackenzie A. Scully's co-authors include Emily S. Day, Jenna C. Harris, Megan N. Dang, Danielle M. Valcourt, Chintan H. Kapadia, Kejian Li, Rachel Riley and G. de M. Azevedo and has published in prestigious journals such as ACS Nano, Advanced Healthcare Materials and Cancers.

In The Last Decade

Mackenzie A. Scully

11 papers receiving 402 citations

Peers

Mackenzie A. Scully

BE

MB

BIOMA

IMMUN

MC

Jenna C. Harris United States

Marcin Wojnilowicz Australia

Shilpa Scaria United States

Chandra Kumar Elechalawar United States

Jican Liu China

Julien Couture‐Senécal Canada

Christopher D. Sarsons Canada

Suyog Shaha United States

Erica Quagliarini Italy

Jenna C. Harris United States

Mackenzie A. Scully

251 ×1.0

BE

181 ×0.9

MB

184 ×1.0

BIOMA

44 ×1.1

IMMUN

44 ×1.1

MC

Citations per year, relative to Mackenzie A. Scully Mackenzie A. Scully (= 1×) peers Jenna C. Harris

Countries citing papers authored by Mackenzie A. Scully

Since Specialization

Citations

This map shows the geographic impact of Mackenzie A. Scully's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mackenzie A. Scully with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mackenzie A. Scully more than expected).

Fields of papers citing papers by Mackenzie A. Scully

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mackenzie A. Scully. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mackenzie A. Scully. The network helps show where Mackenzie A. Scully may publish in the future.

Co-authorship network of co-authors of Mackenzie A. Scully

This figure shows the co-authorship network connecting the top 25 collaborators of Mackenzie A. Scully. A scholar is included among the top collaborators of Mackenzie A. Scully based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mackenzie A. Scully. Mackenzie A. Scully is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Azevedo, G. de M., et al.. (2025). Cancer Cell Membrane-Wrapped Nanoparticles for Photothermal Therapy and Photoacoustic Imaging of Triple-Negative Breast Cancer. ACS Applied Nano Materials. 8(35). 17311–17328. 1 indexed citations

2.

Scully, Mackenzie A., et al.. (2024). Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer. ACS Biomaterials Science & Engineering. 10(3). 1355–1363. 9 indexed citations

3.

Dang, Megan N., et al.. (2024). Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple‐Negative Breast Cancer. Advanced Therapeutics. 7(6). 7 indexed citations

4.

Scully, Mackenzie A., et al.. (2023). Combination cancer imaging and phototherapy mediated by membrane-wrapped nanoparticles. International Journal of Hyperthermia. 40(1). 2272066–2272066. 5 indexed citations

5.

Scully, Mackenzie A., et al.. (2023). Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer. Molecular Pharmaceutics. 20(8). 3895–3913. 18 indexed citations

6.

Scully, Mackenzie A., et al.. (2022). Membrane-wrapped nanoparticles for photothermal cancer therapy. Nano Convergence. 9(1). 37–37. 43 indexed citations

7.

Scully, Mackenzie A., et al.. (2022). Membrane-wrapped nanoparticles for nucleic acid delivery. Biomaterials Science. 10(16). 4378–4391. 15 indexed citations

8.

Dang, Megan N., et al.. (2021). Antibody nanocarriers for cancer management. Current Opinion in Biomedical Engineering. 19. 100295–100295. 6 indexed citations

9.

Valcourt, Danielle M., Megan N. Dang, Mackenzie A. Scully, & Emily S. Day. (2020). Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer. ACS Nano. 14(3). 3378–3388. 65 indexed citations

10.

Valcourt, Danielle M., Chintan H. Kapadia, Mackenzie A. Scully, Megan N. Dang, & Emily S. Day. (2020). Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines. Advanced Healthcare Materials. 9(12). e2000110–e2000110. 21 indexed citations

11.

Harris, Jenna C., Mackenzie A. Scully, & Emily S. Day. (2019). Cancer Cell Membrane-Coated Nanoparticles for Cancer Management. Cancers. 11(12). 1836–1836. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact